Brief: Quince Therapeutics Files For Common Stock Offering Of Up To $21.9 Million - SEC Filing
24/03/2025 22:04
March 24 (Reuters) - Quince Therapeutics Inc QNCX.O: QUINCE THERAPEUTICS FILES FOR COMMON STOCK OFFERING OF UP TO $21.9 MILLION - SEC FILING Source text: [ID:n0001193125-25-061458] Further company coverage: QNCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges